awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40693959-74239162-BA0F-4225-89D2-72D30E576C9D
Q40693959-74239162-BA0F-4225-89D2-72D30E576C9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40693959-74239162-BA0F-4225-89D2-72D30E576C9D
Decrease in tumor enhancement on contrast-enhanced CT is associated with improved survival in patients with hepatocellular carcinoma treated with Sorafenib.
P2860
Q40693959-74239162-BA0F-4225-89D2-72D30E576C9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40693959-74239162-BA0F-4225-89D2-72D30E576C9D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3132481c5ba94d890d82e26ac5dda5f631895ac2
P2860
Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma.